Towheed, Atif
Goldstein, Amy C. http://orcid.org/0000-0001-6593-5905
Article History
Accepted: 22 December 2022
First Online: 10 February 2023
Declarations
:
: A retrospective chart review of the clinical course and laboratory test results was performed for patients presented. Informed consent was provided, and all patients were enrolled in the Children’s Hospital of Philadelphia (CHOP) Institutional Review Board (IRB) approved study #08–6177 (Marni J. Falk, PI) that allows for medical record reviews, medical photography, publication for educational purposes, and clinical cohort analyses.
: Dr Atif Towheed declares no conflict of interest. Dr Amy Goldstein is a consultant for Reneo Pharmaceuticals and on the Speakers Bureau for United Mitochondrial Disease Foundation and MitoAction.
: This article does not contain any studies with human or animal subjects performed by any of the authors.